Literature DB >> 23576767

The relationship between depressive symptoms and restless legs syndrome in two prospective cohort studies.

Andras Szentkiralyi1, Henry Völzke, Wolfgang Hoffmann, Bernhard T Baune, Klaus Berger.   

Abstract

OBJECTIVE: Cross-sectional studies suggest a strong association between depression and restless legs syndrome (RLS); however, the temporal relationship between the two disorders remains unknown. We tested whether the presence of clinically relevant depressive symptoms (CRDS) is a risk factor for subsequent RLS in the general population. The relationship between prevalent RLS and incident CRDS was also examined.
METHODS: Two independent, prospective cohort studies with representative, age-stratified random samples, the Dortmund Health Study (DHS; n = 1312/1122 [baseline/follow-up], median follow-up time = 2.1 years) and the Study of Health in Pomerania (SHIP; n = 4308/3300, median follow-up time = 5.0 years) were analyzed. RLS was assessed in both studies according to the RLS minimal criteria, at baseline and at follow-up. CRDS were assessed by the Center for Epidemiologic Studies-Depression scale (a score of ≥16) in DHS only at baseline and by the Munich-Composite International Diagnostic-Screener in SHIP at baseline and at follow-up.
RESULTS: Clinically relevant depressive symptoms at baseline were associated new-onset RLS in both studies (DHS: odds ratio [OR] = 1.94, 95% confidence interval [CI] = 1.09-3.44; SHIP: OR = 2.37, 95% CI = 1.65-3.40) after adjustment for age, sex, education, body mass index, smoking, physical activity, and the presence of various comorbidities. RLS at baseline was an independent risk factor of incident CRDS in SHIP (OR = 1.82, 95% CI = 1.10-3.00).
CONCLUSIONS: The presence of CRDS may be a risk factor for subsequent RLS. The relationship between the two disorders might be bidirectional because RLS also predicts incident depressive symptoms.

Entities:  

Keywords:  cohort study; depressive disorders; epidemiology; general population; restless legs syndrome; risk factors

Mesh:

Year:  2013        PMID: 23576767     DOI: 10.1097/PSY.0b013e31828bbbf1

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  7 in total

1.  Prospective study of obesity, hypertension, high cholesterol, and risk of restless legs syndrome.

Authors:  Katerina De Vito; Yanping Li; Salma Batool-Anwar; Yi Ning; Jiali Han; Xiang Gao
Journal:  Mov Disord       Date:  2014-04-21       Impact factor: 10.338

2.  Increased Risk for New-Onset Psychiatric Adverse Events in Patients With Newly Diagnosed Primary Restless Legs Syndrome Who Initiate Treatment With Dopamine Agonists: A Large-Scale Retrospective Claims Matched-Cohort Analysis.

Authors:  Cheryl Hankin; Daniel Lee; Diego Garcia-Borreguero; Zhaohui Wang
Journal:  J Clin Sleep Med       Date:  2019-09-15       Impact factor: 4.062

3.  [Practical guidelines for diagnosis and therapy of restless legs syndrome].

Authors:  M Krenzer; W Oertel; C Trenkwalder
Journal:  Nervenarzt       Date:  2014-01       Impact factor: 1.214

4.  Lack of Association between Genetic Risk Loci for Restless Legs Syndrome and Multimorbidity.

Authors:  András Szentkirályi; Henry Völzke; Wolfgang Hoffmann; Julianne Winkelmann; Klaus Berger
Journal:  Sleep       Date:  2016-01-01       Impact factor: 5.849

5.  Pre-pregnancy restless legs syndrome (Willis-Ekbom Disease) is associated with perinatal depression.

Authors:  Jan Wesström; Alkistis Skalkidou; Mauro Manconi; Stephany Fulda; Inger Sundström-Poromaa
Journal:  J Clin Sleep Med       Date:  2014-05-15       Impact factor: 4.062

6.  Evaluation of affective temperament profile and levels of depressive symptoms and anxiety in patients with restless legs syndrome.

Authors:  Sehnaz Basaran; Halil İbrahim Tas
Journal:  Sleep Breath       Date:  2021-04-21       Impact factor: 2.816

7.  Restless Legs Syndrome Prevalence and Clinical Correlates Among Psychiatric Inpatients: A Multicenter Study.

Authors:  Franziska C Weber; Heidi Danker-Hopfe; Ezgi Dogan-Sander; Lukas Frase; Anna Hansel; Nicole Mauche; Christian Mikutta; Diana Nemeth; Kneginja Richter; Claudia Schilling; Martina Sebestova; Marian M Spath; Christoph Nissen; Thomas C Wetter
Journal:  Front Psychiatry       Date:  2022-03-14       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.